Top Ranked Momentum Stocks to Buy for November 27th

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, November 27th:

Care.com, Inc. (CRCM): This provider of online marketplace for finding and managing family care has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 29.3% over the last 60 days.

Care.com, Inc. Price and Consensus

Care.com, Inc. Price and Consensus | Care.com, Inc. Quote

Care.com’s shares gained 21.9% over the last one month more than S&P 500’s gain of 1.6%. The company possesses a Momentum Score of B.

Care.com, Inc. Price

Care.com, Inc. Price

Care.com, Inc. price | Care.com, Inc. Quote

Vector Group Ltd. (VGR): This manufacturer and seller of cigarettes has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.1% over the last 60 days.

Vector Group Ltd. Price and Consensus

Vector Group Ltd. Price and Consensus | Vector Group Ltd. Quote

Vector Group’s shares gained 8.2% over the last one month. The company possesses a Momentum Score of B.

Vector Group Ltd. Price

Vector Group Ltd. Price

Vector Group Ltd. price | Vector Group Ltd. Quote

TriNet Group, Inc. (TNET): This human resources solutions provider has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 33.6% over the last 60 days.

TriNet Group, Inc. Price and Consensus

TriNet Group, Inc. Price and Consensus | TriNet Group, Inc. Quote

TriNet Group’s shares gained 27.4% over the last one month. The company possesses a Momentum Score of B.

TriNet Group, Inc. Price

TriNet Group, Inc. Price

TriNet Group, Inc. price | TriNet Group, Inc. Quote

Collegium Pharmaceutical, Inc. (COLL): This developer of abuse-deterrent products has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 14.7% over the last 60 days.

Collegium Pharmaceutical, Inc. Price and Consensus

Collegium Pharmaceutical, Inc. Price and Consensus | Collegium Pharmaceutical, Inc. Quote

Collegium Pharmaceutical’s shares gained 64.5% over the last one month. The company possesses a Momentum Score of A.

Collegium Pharmaceutical, Inc. Price

Collegium Pharmaceutical, Inc. Price

Collegium Pharmaceutical, Inc. price | Collegium Pharmaceutical, Inc. Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.

Click here for the 6 trades >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Vector Group Ltd. (VGR) : Free Stock Analysis Report
 
TriNet Group, Inc. (TNET) : Free Stock Analysis Report
 
Care.com, Inc. (CRCM) : Free Stock Analysis Report
 
Collegium Pharmaceutical, Inc. (COLL) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research